Detailseite
Projekt Druckansicht

Strukturbiologische Untersuchung der mRNA Erkennung durch FMRP und TDP-43, zwei RNA bindende Proteine die mit neuronalen Krankheiten assoziiert sind

Antragsteller Dr. Klaas Max
Fachliche Zuordnung Strukturbiologie
Förderung Förderung von 2010 bis 2012
Projektkennung Deutsche Forschungsgemeinschaft (DFG) - Projektnummer 192380013
 
Erstellungsjahr 2014

Zusammenfassung der Projektergebnisse

The deregulation of posttranscriptional regulatory networks by genetic mutation, deletion or overexpression of RNA-binding proteins results in disease, yet their target RNAs and their modes of regulation are largely unknown. Many neurodegenerative conditions are caused by altered RBP expression that perturbs post-transcriptional regulatory networks. Examples include Fragile-X-Syndrome (FXS) and amyotrophic lateral sclerosis (ALS). This research project was aimed to understand the recognition of mRNA targets to deduce the regulatory principles of two disease-associated RBPs, one of which (FMRP) is associated with the FXS and particular types of autism, whereas mutations in the other (TDP-43) are associated with ALS. Molecular RNA targets of these RBPs were identified using PAR-CLIP (photoactivatable ribonucleotide crosslinking and immunoprecipitation) in combination with high-throughput sequencing. This allowed an efficient identification of cellular RNA targets and the determination of RNA recognition elements from their consensus sequences. The RBPs were analyzed in the presence and absence of their biologically relevant RNA targets as well as further interaction partners using biophysical and structural-biology methods. This approach went beyond analyses of short RNA fragments with isolated RNA-binding domains. Results on the molecular structure and folding states of the RBPs in the presence and absence of their ligands allowed the generation of hypotheses of their molecular function and regulation, which were be investigated using "in-vitro" models and living cells. An understanding of RBPs at the molecular level as well as in a cellular environment may contribute to the development of specific pharmacological interventions.

Projektbezogene Publikationen (Auswahl)

 
 

Zusatzinformationen

Textvergrößerung und Kontrastanpassung